Immunization against the murine malaria parasite Plasmodium yoelii using a recombinant protein with adjuvants developed for clinical use. (Q48037488)

7 February 2018

title

Immunization against the murine malaria parasite Plasmodium yoelii using a recombinant protein with adjuvants developed for clinical use. (English)

1 reference

7 February 2018

0 references

0 references

1 reference

8

1 reference

7 February 2018

W Ripley Ballou

7

object named as

W R Ballou

1 reference

7 February 2018

author name string

I T Ling

1

1 reference

7 February 2018

S A Ogun

2

1 reference

7 February 2018

P Momin

3

1 reference

7 February 2018

R L Richards

4

1 reference

7 February 2018

N Garçon

5

1 reference

7 February 2018

J Cohen

6

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 October 1997

1 reference

7 February 2018

published in

Vaccine

1 reference

7 February 2018

volume

15

1 reference

7 February 2018

issue

14

1 reference

7 February 2018

page(s)

1562-1567

1 reference

7 February 2018

The major merozoite surface protein as a malaria vaccine target

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900076-5

7 January 2021

A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900076-5

7 January 2021

Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900076-5

7 January 2021

A malaria merozoite surface protein (MSP1)-structure, processing and function

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900076-5

7 January 2021

Sequence heterogeneity of the C-terminal, Cys-rich region of the merozoite surface protein-1 (MSP-1) in field samples of Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900076-5

7 January 2021

Mapping of the region predominantly recognized by antibodies to the Plasmodium falciparum merozoite surface antigen MSA 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900076-5

7 January 2021

Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900076-5

7 January 2021

Immunization against malaria with a recombinant protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900076-5

7 January 2021

Immunization against Plasmodium falciparum with recombinant polypeptides produced in Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900076-5

7 January 2021

Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900076-5

7 January 2021

A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900076-5

7 January 2021

Vaccination of mice against malaria with soluble antigens. I. The effect of detergent, route of injection, and adjuvant.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900076-5

7 January 2021

Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900076-5

7 January 2021

Cloning and analysis of the gene encoding the 230-kilodalton merozoite surface antigen of Plasmodium yoelii

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900076-5

7 January 2021

Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900076-5

7 January 2021

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900076-5

7 January 2021

Plasmodium yoelii: Antibody and the maintenance of immunity in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900076-5

7 January 2021

Inbred mice infected with Plasmodium yoelii differ in their antimalarial immunoglobulin isotype response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900076-5

7 January 2021

The combined epidermal growth factor-like modules of Plasmodium yoelii Merozoite Surface Protein-1 are required for a protective immune response to the parasite.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900076-5

7 January 2021

The potential for recruiting immune responses toward type 1 or type 2 T cell help.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900076-5

7 January 2021

Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900076-5

7 January 2021

10.1016/S0264-410X(97)00076-5

Identifiers

DOI

1 reference

7 February 2018

PubMed ID

9330469

1 reference

7 February 2018